Robotic walking exoskeleton for children with spinal cord injury
Tests the ATLAS 2030 exoskeleton for safety and usability in children with spinal cord injury.
Key facts
- Who runs it
- MarsiBionics
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 17 Feb 2025
- Planned end
- 1 Feb 2026
- Type of study
- Interventional
- Treatments tested
- Rehabilitation treatment with ATLAS2030
- Record updated
- 14 August 2025
Who can take part
The trial is looking for children aged 3 to 14 with a subacute or chronic spinal cord injury. They will train standing and walking with the ATLAS 2030 robotic exoskeleton.
- Age
- 3 to 14 years
- Sex
- All sexes
- Disease stage
- Subacute or chronic spinal cord injury. The child must be clinically stable and well enough for the training program. A doctor must allow standing and walking training with weight on the legs. Body size must fit the device: weight ≤ 35 kg (77 lb), hip width ≤ 34 cm (13 in), femur length between 24 cm (9.4 in) and 33 cm (13 in), tibia length between 23 cm (9.1 in) and 32 cm (13 in), EU shoe size between 27 and 33. Some shorter leg lengths can be accepted under conditions.
- Earlier treatment
- Children cannot join if they have previous orthopedic surgery on the spine or legs that rules out the treatment, or surgery planned during the study.
- Main reasons for not taking part
- Severe stiffness of the leg muscles (Modified Ashworth Scale = 4), or hip or knee contracture > 20 degrees
- Advanced osteoporosis, unstable fractures, or leg or pelvis fractures from injury within the past 6 months
- Frequent seizures, uncontrolled epilepsy, or hard-to-control behavior disorders
- Uncontrolled heart or lung disease, or another condition that makes exercise hard
- Severe skin wounds where the device touches, or allergy to the device materials
Show the full registry criteria (24)Hide the full registry criteria
Who can take part
- Having a subacute or chronic spinal cord injury (SCI) and being clinically stable with a general condition good enough to participate in the therapeutic program with the ATLAS 2030
- Age between 3 and 14 years
- Medical authorization to perform standing and gait training with weight-bearing
- Consent from the participant or legal guardian to participate in the study
- Adequate level of acceptance and commitment from the family
- Weight ≤ 35 kg
- Hip width ≤ 34 cm. It is advised that for measurements under 28 cm, verification should be performed to ensure there is no excessive base of support that might induce foot inversion in the standing position
- Femur length (distance from the greater trochanter to the lateral condyle of the femur) between 24 cm and 33 cm. Femur lengths shorter than 24 cm are acceptable as long as the hip motor of the device does not extend above the user's iliac crest, avoiding hypermobility of the lumbar spine
- Tibia length (distance from the lateral condyle to the lateral malleolus of the tibia) between 23 cm and 32 cm. Tibia lengths shorter than 23 cm are acceptable as long as they can be compensated with a lift and the user's ankle joint remains within the area of the ankle motor
- EU shoe size between 27 and 33
Who cannot take part
- Planned surgical intervention during the study period or previous orthopedic surgery on the spine and/or lower limbs contraindicating treatment
- Known advanced osteoporosis evidenced by bone densitometry, particularly with a history of prior fractures or fractures without trauma. Traumatic bone fractures in the lower limbs or pelvic girdle within the past 6 months
- Presence of frequent seizures, uncontrolled epilepsy, or difficult-to-control behavioral disorders
- Presence of decompensated heart or lung disease, or any other condition causing exercise intolerance
- Allergy to any of the materials used in the ATLAS 2030: cotton, nylon, polyester, polyamide, polyethylene, or polypropylene
- Impossibility for the family to complete treatment schedule planning
- Any contraindication for standing and/or walking
- Spasticity (Modified Ashworth Scale (MAS) = 4 in the lower limbs at the time of device use)
- Joint contracture of the hip and/or knee > 20 degrees
- Need to walk with more than 9 degrees of hip abduction
- Need to walk with more than 9 degrees of dorsal or plantar ankle flexion, or inability to use an orthosis to achieve 90° at the ankle
- Severe skin lesions in areas of contact with the device
- Unstable fractures, joint dislocations, or other joint pathologies in the trunk and lower limbs contraindicating the treatment
- Severe rigid orthopedic deformities of the spine that prevent the use of the device
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Spinal cord injury
This trial is currently available in Spain.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to analyze the usability and safety of the robotic gait ATLAS 2030 in a cohort of pediatric patients with Spinal Cord Injury, with the aim of extending its indication for use to pediatric spinal cord injury
The group in the trial
- Robot Asissted Gait TrainingTreatment being tested
The rehabilitation sessions will be carried out by a physiotherapist trained in rehabilitation with the ATLAS 2030 exoskeleton
Treatment: Rehabilitation treatment with ATLAS2030
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury
- Plain-language title
- Robotic walking exoskeleton for children with spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06772077, who can take part
- Record updated
- 14 August 2025